2014
DOI: 10.1097/inf.0000000000000207
|View full text |Cite
|
Sign up to set email alerts
|

Norovirus GII.4 Antibodies in Breast Milk and Serum Samples

Abstract: Breast milk inhibits norovirus GII.4-2006b VLPs binding to receptors in saliva, and anti-norovirus IgA antibodies are only partly responsible for this activity. The FUT2 status of the receptor seems to be a strong predictor of this effect, but more studies to ascertain the participation of histo-blood group antigens in the protection against norovirus infections elicited by breast milk are required.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 34 publications
1
5
0
Order By: Relevance
“…We showed that breast milk samples collected before and during the first NV infection of infants contained multiple NV-IgA using an in-house ELISA-based method which was concordant with the previous studies on postpartum breast milk [14] , [15] , [16] . In our study, Peruvian mothers had a higher percent positivity (61–100%) of NV-IgA in breast milk than mothers in these studies.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…We showed that breast milk samples collected before and during the first NV infection of infants contained multiple NV-IgA using an in-house ELISA-based method which was concordant with the previous studies on postpartum breast milk [14] , [15] , [16] . In our study, Peruvian mothers had a higher percent positivity (61–100%) of NV-IgA in breast milk than mothers in these studies.…”
Section: Discussionsupporting
confidence: 89%
“…Previous studies showed that breast milk collected postpartum reacted to various NV virus-like particles (VLPs), but the protective ability of NV-specific IgA (NV-IgA) is yet to be established [14] , [15] , [16] . In this study, we evaluated the linkage of NV-IgA in breast milk with protection against NV and found that (i) NV-IgA reacted against GII·4 variants and non-GII·4 genotype VLPS, and (ii) high titer of NV-IgA was associated to the reduction of diarrheal symptoms in NV infected infants.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have shown that human breast milk from mothers with the secretor phenotype contains fucosylated oligosaccharides, which can act as such a blockade against the binding of norovirus virus–like particles [30, 31]. …”
Section: Discussionmentioning
confidence: 99%
“…Here, the Lewis blood group and secretor status of the mother are of particular importance. They are currently discussed to have an influence on inflammatory gastrointestinal diseases, on adverse outcomes in low-birth-weight infants or on diarrhea (17)(18)(19)(20)(21)(22)(23). Feeding infants with a different HMO pattern may reduce or even increase the risk for certain diseases.…”
Section: What Is Newmentioning
confidence: 99%